PNC Financial Services Group Inc. lowered its stake in QuidelOrtho Co. (NASDAQ:QDEL – Free Report) by 11.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,622 shares of the company’s stock after selling 590 shares during the quarter. PNC Financial Services Group Inc.’s holdings in QuidelOrtho were worth $341,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Citigroup Inc. boosted its holdings in shares of QuidelOrtho by 25.0% in the third quarter. Citigroup Inc. now owns 5,808 shares of the company’s stock valued at $424,000 after acquiring an additional 1,161 shares in the last quarter. Mariner LLC lifted its position in QuidelOrtho by 10.3% in the third quarter. Mariner LLC now owns 8,505 shares of the company’s stock worth $621,000 after purchasing an additional 797 shares during the period. Rubric Capital Management LP bought a new position in QuidelOrtho during the 3rd quarter valued at $21,651,000. Comerica Bank acquired a new position in shares of QuidelOrtho during the 3rd quarter valued at $5,156,000. Finally, Wellington Management Group LLP raised its stake in shares of QuidelOrtho by 11.2% in the 3rd quarter. Wellington Management Group LLP now owns 760,632 shares of the company’s stock worth $55,557,000 after buying an additional 76,866 shares in the last quarter. Institutional investors own 99.00% of the company’s stock.
Insiders Place Their Bets
In other news, major shareholder Carlyle Group Inc. sold 127,981 shares of the firm’s stock in a transaction on Friday, June 14th. The stock was sold at an average price of $36.19, for a total value of $4,631,632.39. Following the completion of the sale, the insider now owns 12,123,705 shares of the company’s stock, valued at $438,756,883.95. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In the last three months, insiders have sold 514,288 shares of company stock worth $18,383,593. Corporate insiders own 1.00% of the company’s stock.
Analysts Set New Price Targets
Check Out Our Latest Stock Report on QuidelOrtho
QuidelOrtho Trading Down 0.9 %
Shares of QDEL opened at $33.22 on Friday. The business’s 50-day moving average price is $40.46 and its 200 day moving average price is $51.74. The company has a current ratio of 1.55, a quick ratio of 0.81 and a debt-to-equity ratio of 0.68. The stock has a market capitalization of $2.22 billion, a P/E ratio of -1.26 and a beta of 0.13. QuidelOrtho Co. has a 1-year low of $32.47 and a 1-year high of $89.11.
QuidelOrtho (NASDAQ:QDEL – Get Free Report) last released its earnings results on Wednesday, May 8th. The company reported $0.36 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.06). The firm had revenue of $711.00 million during the quarter, compared to analysts’ expectations of $697.33 million. QuidelOrtho had a positive return on equity of 3.96% and a negative net margin of 61.65%. Analysts expect that QuidelOrtho Co. will post 1.85 earnings per share for the current year.
About QuidelOrtho
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions.
Featured Articles
- Five stocks we like better than QuidelOrtho
- What Do S&P 500 Stocks Tell Investors About the Market?
- What’s Behind Walgreens Stock Plunge: What Investors Can Do Next
- Transportation Stocks Investing
- MarketBeat Week in Review – 6/24 – 6/28
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- General Mills Stock Drops After Revenue Miss in Fiscal Q4 2024
Want to see what other hedge funds are holding QDEL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for QuidelOrtho Co. (NASDAQ:QDEL – Free Report).
Receive News & Ratings for QuidelOrtho Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QuidelOrtho and related companies with MarketBeat.com's FREE daily email newsletter.